S100A9 and Alzheimer disease: We confirmed that the protein levels of S100A8 and S100A9 (S100A8/9) in the serum of DNCB-induced AD-like model mice were significantly elevated and that cessation of AD induction resulted in marked decreases, as assessed by ELISA (Figure 6f).